Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Dianomi Therapeutics

Dianomi Therapeutics
2017 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Corporate LATEST DEAL TYPE
$3M LATEST DEAL AMOUNT
1 INVESTORS
Description

Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially targeting osteoarthritis (OA). The company's mineral coated microparticle (MCM) technology has the ability to provide sustained release delivery of active biologics, an issue many traditional drug delivery systems struggle with, providing patients with improved, sustained-release delivery of active biologics.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 504 South Rosa Road
  • Suite 200
  • Madison, WI 53719
  • United States

+1 (303) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Dianomi Therapeutics’s full profile, request a free trial.

Dianomi Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Corporate 04-Feb-2019 $3M 00.000 Completed Pre-Clinical Trials
1. Angel (individual) 25-Jan-2019 00000 00000 Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

Dianomi Therapeutics Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CrossBeta Biosciences Formerly VC-backed Utrecht, Netherlands 00 00.00 000000&0 00.00
0000000 0000000000 Venture Capital-Backed Bozeman, MT 0 000.00 000000000000 000.00
0000000 0000000 Venture Capital-Backed Switzerland 00.000 00000000000 00.000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
00000 Formerly PE-Backed Paris, France 00 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Dianomi Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ligand Pharmaceuticals Corporation Minority 000 0000 000000 0

Dianomi Therapeutics Executive Team (6)

Name Title Board
Seat
Contact
Info
Barry Kurokawa Co-Founder, Chief Executive Officer & Board Member
William Murphy Ph.D Co-Founder, Chief Scientific Officer & Board Member
Anna Clements Ph.D Co-Founder & Sr. Scientist
Kurtis Knapp Ph.D Co-Founder & Board Member
Martin Ostrowski Co-Founder, Chief Operating Officer, General Counsel & Board Member
You’re viewing 5 of 6 executives. Get the full list »

Dianomi Therapeutics Board Members (5)

Name Representing Role Since Contact
Info
Barry Kurokawa Dianomi Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
Carter Cliff Ph.D Self Co-Founder & Board Member 000 0000
Kurtis Knapp Ph.D Dianomi Therapeutics Co-Founder & Board Member 000 0000
Martin Ostrowski Self Co-Founder, Chief Operating Officer, General Counsel & Board Member 000 0000
William Murphy Ph.D Dianomi Therapeutics Co-Founder, Chief Scientific Officer & Board Member 000 0000